| Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii J Vila, S Martí, J Sanchez-Céspedes Journal of antimicrobial chemotherapy 59 (6), 1210-1215, 2007 | 640 | 2007 |
| Quinolone resistance in the food chain A Fàbrega, J Sánchez-Céspedes, S Soto, J Vila International journal of Antimicrobial agents 31 (4), 307-315, 2008 | 186 | 2008 |
| Perspectives for clinical use of engineered human host defense antimicrobial peptides ME Pachón-Ibáñez, Y Smani, J Pachon, J Sanchez-Cespedes FEMS microbiology reviews 41 (3), 323-342, 2017 | 156 | 2017 |
| Prevalence of mechanisms decreasing quinolone-susceptibility among Salmonella spp. clinical isolates AD Lunn, A Fàbrega, J Sánchez-Céspedes, J Vila Int Microbiol 13 (1), 15-20, 2010 | 91 | 2010 |
| Mechanism of binding of fluoroquinolones to the quinolone resistance‐determining region of DNA gyrase: Towards an understanding of the molecular basis of quinolone resistance S Madurga, J Sánchez‐Céspedes, I Belda, J Vila, E Giralt Chembiochem 9 (13), 2081-2086, 2008 | 63 | 2008 |
| Development of imipenem resistance in an Aeromonas veronii biovar sobria clinical isolate recovered from a patient with cholangitis J Sanchez-Cespedes, MJ Figueras, C Aspiroz, MJ Aldea, M Toledo, ... Journal of medical microbiology 58 (4), 451-455, 2009 | 61 | 2009 |
| Quorum-sensing regulator sdiA and marA overexpression is involved in in vitro-selected multidrug resistance of Escherichia coli MM Tavío, VD Aquili, JB Poveda, NT Antunes, J Sánchez-Céspedes, ... Journal of Antimicrobial Chemotherapy 65 (6), 1178-1186, 2010 | 60 | 2010 |
| Detection of dihydrofolate reductase genes by PCR and RFLP MM Navia, J Ruiz, J Sanchez-Cespedes, J Vila Diagnostic microbiology and infectious disease 46 (4), 295-298, 2003 | 56 | 2003 |
| Plasmid-Mediated QnrS2 Determinant from a Clinical Aeromonas veronii Isolate J Sánchez-Céspedes, MD Blasco, S Marti, V Alba, E Alcalde, C Esteve, ... Antimicrobial agents and chemotherapy 52 (8), 2990-2991, 2008 | 55 | 2008 |
| Repositioning salicylanilide anthelmintic drugs to treat adenovirus infections JA Marrugal-Lorenzo, A Serna-Gallego, J Berastegui-Cabrera, J Pachón, ... Scientific reports 9 (1), 17, 2019 | 48 | 2019 |
| Proteomic analysis of a fraction enriched in cell envelope proteins of Acinetobacter baumannii S Martí, J Sánchez‐Céspedes, E Oliveira, D Bellido, E Giralt, J Vila Proteomics 6 (S1), S82-S87, 2006 | 48 | 2006 |
| In vitro activity of doripenem against Acinetobacter baumannii clinical isolates S Marti, J Sánchez-Céspedes, V Alba, J Vila International Journal of Antimicrobial Agents 33 (2), 181-182, 2009 | 46 | 2009 |
| Autoantibodies against type I IFNs in patients with critical influenza pneumonia Q Zhang, A Pizzorno, L Miorin, P Bastard, A Gervais, T Le Voyer, L Bizien, ... Journal of Experimental Medicine 219 (11), e20220514, 2022 | 44 | 2022 |
| Antiadenovirus drug discovery: potential targets and evaluation methodologies P Martinez-Aguado, A Serna-Gallego, JA Marrugal-Lorenzo, ... Drug Discovery Today 20 (10), 1235-1242, 2015 | 38 | 2015 |
| Excretion and viability of SARS-CoV-2 in feces and its association with the clinical outcome of COVID-19 C Cerrada-Romero, J Berastegui-Cabrera, P Camacho-Martínez, ... Scientific Reports 12 (1), 7397, 2022 | 37 | 2022 |
| Inhibition of adenovirus replication by a trisubstituted piperazin-2-one derivative J Sanchez-Cespedes, CL Moyer, LR Whitby, DL Boger, GR Nemerow Antiviral research 108, 65-73, 2014 | 37 | 2014 |
| Multiple multicomponent reactions: unexplored substrates, selective processes, and versatile chemotypes in biomedicine O Ghashghaei, S Caputo, M Sintes, M Revés, N Kielland, C Estarellas, ... Chemistry–A European Journal 24 (54), 14513-14521, 2018 | 36 | 2018 |
| Antibacterial evaluation of a collection of norfloxacin and ciprofloxacin derivatives against multiresistant bacteria J Vila, J Sánchez-Céspedes, JM Sierra, M Piqueras, E Nicolas, J Freixas, ... International journal of antimicrobial agents 28 (1), 19-24, 2006 | 36 | 2006 |
| Characterization of the Carbapenem-Hydrolyzing Oxacillinase Oxa-58 in an Acinetobacter Genospecies 3 Clinical Isolate S Marti, J Sánchez-Céspedes, MD Blasco, M Ruiz, P Espinal, V Alba, ... Antimicrobial agents and chemotherapy 52 (8), 2955-2958, 2008 | 35 | 2008 |
| New 4-acyl-1-phenylaminocarbonyl-2-phenylpiperazine derivatives as potential inhibitors of adenovirus infection. synthesis, biological evaluation, and structure–activity … J Sánchez-Céspedes, P Martínez-Aguado, M Vega-Holm, ... Journal of Medicinal Chemistry 59 (11), 5432-5448, 2016 | 32 | 2016 |
Jordi VilaDepartment of Clinical Microbiology, Hospital ClinicVerified email at clinic.ub.es
